Healthcare & Life Sciences
Immunai
New York City, United Statesimmunai.com
Immunai is a series b startup based in United States. 1 investor tracked.
Activeseries-c-plus
series-c-plus
Stage
2020
Founded
2
Investors
About Immunai
Immunai is a startup founded in 2020 based in New York City, the United States. Its most recent tracked round is Series C+. Brouky classifies it under Healthcare & Life Sciences. Brouky records 2 investors associated with the company.
Immunai develops an AI-driven platform that maps the human immune system to enhance drug discovery and development, utilizing multi-omic data and machine learning to predict patient responses and identify therapeutic targets.
Explore Immunai's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.